King’s Clinical Trials Unit

Academic Director

Professor Peter Sasieni is the Academic Director of the Kings Clinical Trials Unit and Professor of Cancer Prevention. He is known for his research in medical statistics and cancer epidemiology and his work influences both policy and practice.

The King’s Clinical Trials Unit is fully registered by the UKCRC and receives support funding from the NIHR and the biomedical research centre for mental health. The UKCRC registered King’s Clinical Trials Unit is available to provide support to academic led trials across KHP and externally.

For academic collaborations with statistics, health economics, qualitative social science and operational support, the KCTU must be approached at the grant application stage, ideally 3-4 months in advance of the submission deadline. Requests for academic collaboration made post-funding award or close to the submission deadline are unlikely to be successful.

Currently there are approximately 175 ongoing academic led clinical trials sponsored or co-sponsored by a KHP organisation.

The King’s CTU has been awarded full CTU registration by the UKCRC.

This unit receives National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.
NIHR logo


Service level support for web based randomisation and eCRF systems are usually available to all trials. Requests for service level support may be submitted at any time, whether pre- or post-funding award. The costing model for these services can be found under the ‘KCTU Support’ or by visiting the links below. These are provided publicly to help researchers estimate likely costs, but it is recommended that a formal quote is requested prior to grant submission.

As KCTU receives infrastructure support from NIHR, priority for academic collaborations will be given to NIHR funding streams. KCTU support or collaboration is agreed formally at monthly senior management meetings.

To request support, please submit a completed support request form here.

The KCTU manages a bespoke online randomisation system, supporting simple randomisation, block randomisation, stratified block randomisation and minimisation.

The KCTU has hosted a commercial data entry system (InferMed MACRO) since 2005. It has also been used for other complex intervention trials.

Statistical input into research is vital to ensure that data is robustly collected and analysed, thereby providing reliable results which are publishable in high impact journals.

A team of health economists with expertise in conducting high quality economic evaluations of healthcare interventions, modelling studies and cost analyses.

A team of qualitative researchers with expertise in using qualitative research in all stages of the design and conduct of trials.

Please click here to see STAART-AKI Privacy Notice